SCHEMBL4935611

SCHEMBL4935611

C[C](CO)C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27938332 0.74
SCHEMBL20187650 0.74
SCHEMBL29017099 0.71
SCHEMBL5229482 0.71 TDP1 (0.42)
Isopropyl Alcohol SCHEMBL7739794 0.71
SCHEMBL3927423 0.69
SCHEMBL20508958 0.67 ALDH1A1 (0.43)
Propylene Glycol SCHEMBL10422544 0.65
SCHEMBL9572897 0.64
SCHEMBL18421719 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3298011-B1 QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS PRINCIPIA BIOPHARMA INC (US) 2021-11-17 EP claimed
US-20180155340-A1 QUINOLONE DERIVATIVES AS FGFR INHIBITORS PRINCIPIA BIOPHARMA INC. 2018-06-07 US claimed
US-20070015792-A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives MSD K.K. (JP) 2007-01-18 US claimed
CN-101223158-B N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives BANYU PHARMA CO LTD 2013-01-09 CN disclosed
CN-101223158-A N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives BANYU PHARMA CO LTD (JP) 2008-07-16 CN disclosed
US-20080103178-A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives MSD K.K. (JP) 2008-05-01 US disclosed
US-20070015792-A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives MSD K.K. (JP) 2007-01-18 US disclosed